Linda Grais
CIK 1413306 · President and CEO · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$119.3K
Companies
4
Total Filings
53
Lifetime Open-Market Net
-$1.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRVS | Director | 10,000 | $11.93 | $119.3K | $24.5K | 13 | 2025-06-16 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | Director | 491,889 | $28.80 | $14.17M | -$1.55M | 14 | 2024-01-31 |
| PRA Health Sciences, Inc. (PRAH) Delisted | Director | 0 | $165.21 | $0 | $0 | 8 | 2021-07-01 |
| Zosano Pharma Corp (ZSAN) Delisted | Director | 22,500 | $0.56 | $12.5K | $0 | 5 | 2021-06-14 |
Recent Filings · Page 2 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-01 | PRA Health Sciences, Inc. (PRAH) Delisted | Disp (D) | −9,683 | $0 | EDGAR |
| 2021-06-16 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2021-06-03 | PRA Health Sciences, Inc. (PRAH) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2021-01-13 | Oruka Therapeutics, Inc. (ABIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
| 2020-06-12 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-20 | PRA Health Sciences, Inc. (PRAH) Delisted | Grant (A) | +1,324 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.